Special Drug Use-results Survey for Long-term Use(Avacopan)
- Conditions
- Microscopic Polyangiitis (MPA)Granulomatosis With Polyangiitis (GPA)
- Interventions
- Registration Number
- NCT06758271
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Brief Summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
- Detailed Description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Avacopan treatmented Avacopan -
- Primary Outcome Measures
Name Time Method Adverse events 2 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Research site
🇯🇵Multiple Locations, Japan